Sundrug Co (SDGCF) Stock Price & Analysis
SDGCF Stock Chart & Stats
- Day’s Range
- $20.47 - $25.42
- 52-Week Range
- $19.75 - $30.82
- Previous Close
- $22.56
- Volume
- 1,600
- Average Volume (3M)
- 0
- Market Cap
- $2.68B
- Enterprise Value
- $431.73B
- Total Cash (Recent Filing)
- $61.35B
- Total Debt (Recent Filing)
- $47.97B
- Price to Earnings (P/E)
- 13.4
- Beta
- -0.03
- Next Earnings
- Nov 13, 2026 (Est.)
- EPS Estimate
- 0.4
- Next Dividend Ex-Date
- Mar 30, 2027
- Dividend Yield
- 2.94%
Bulls Say, Bears Say
Bulls Say
Steady Revenue Growth
Sustained revenue expansion indicates ongoing customer demand across pharmaceuticals, health and beauty products, and daily necessities. This broad assortment supports repeat visits and provides a durable base for continued store-network sales growth.
Conservative Balance Sheet
A large equity base and moderate leverage provide financial resilience and flexibility for store investment, working-capital needs, and business development. The balance sheet should help Sundrug absorb operating volatility better than a highly leveraged retailer.
Stable Profitability
Consistent operating and net margins show that Sundrug can convert its retail scale and recurring consumer demand into steady profits. Margin stability supports earnings visibility even when individual product categories or operating costs fluctuate.
Bears Say
Weak And Volatile Free Cash Flow
Weak cash conversion can limit funds available for store expansion, shareholder distributions, and debt reduction despite reported earnings. If investment requirements or working-capital swings persist, long-term financial flexibility may remain constrained.
Rising Debt
Although leverage remains moderate, the rising debt trend reduces balance-sheet flexibility and could increase financing needs over time. This becomes more material if profitability softens or free cash flow remains insufficient to fund investment internally.
Gross Margin Pressure
A lower gross margin suggests pressure from merchandise costs, pricing, or sales mix. If sustained, it could limit profit growth even with rising revenue, requiring continued efficiency gains and purchasing scale to protect the retailer’s earnings base.
SDGCF FAQ
What was Sundrug Co’s price range in the past 12 months?
What is Sundrug Co’s market cap?
When is Sundrug Co’s upcoming earnings report date?
How were Sundrug Co’s earnings last quarter?
Is Sundrug Co overvalued?
Does Sundrug Co pay dividends?
What is Sundrug Co’s EPS estimate?
How many shares outstanding does Sundrug Co have?
What happened to Sundrug Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Sundrug Co?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Sundrug Co
Sundrug Co.,Ltd. engages in the drug store business in Japan. It operates through Drug Store Business and Discount Store Business segments. The Drug Store Business segment primarily sells pharmaceutical products, cosmetics, and daily necessities. The Discount Store Business segment offers food and household goods. The company was incorporated in 1957 and is headquartered in Fuchu, Japan.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Hiroshi Sadakata
- Employees
- 7,457
- Website
- www.sundrug.co.jp
- Address
- 1-38-1, Wakamatsucho, Fuchu, TY, 183-0005, JP
Sundrug Co (SDGCF) Earnings & Revenues
SDGCF Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 5 | 6 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 7 | 0 | 5 |








